Cargando…
Identification of Selective ERRγ Inverse Agonists
GSK5182 (4) is currently one of the lead compounds for the development of estrogen-related receptor gamma (ERRγ) inverse agonists. Here, we report the design, synthesis, pharmacological and in vitro absorption, distribution, metabolism, excretion, toxicity (ADMET) properties of a series of compounds...
Autores principales: | Kim, Jina, Im, Chun Young, Yoo, Eun Kyung, Ma, Min Jung, Kim, Sang-Bum, Hong, Eunmi, Chin, Jungwook, Hwang, Hayoung, Lee, Sungwoo, Kim, Nam Doo, Jeon, Jae-Han, Lee, In-Kyu, Jeon, Yong Hyun, Choi, Hueng-Sik, Kim, Seong Heon, Cho, Sung Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273807/ https://www.ncbi.nlm.nih.gov/pubmed/26771593 http://dx.doi.org/10.3390/molecules21010080 |
Ejemplares similares
-
An Inverse Agonist GSK5182 Increases Protein Stability of the Orphan Nuclear Receptor ERRγ via Inhibition of Ubiquitination
por: Na, Soon-Young, et al.
Publicado: (2022) -
Inverse Agonist of Nuclear Receptor ERRγ Mediates Antidiabetic Effect Through Inhibition of Hepatic Gluconeogenesis
por: Kim, Don-Kyu, et al.
Publicado: (2013) -
Molecular dynamics of the ERRγ ligand-binding domain bound with agonist and inverse agonist
por: Sasidharan, Santanu, et al.
Publicado: (2023) -
Hypoxia Induces PDK4 Gene Expression through Induction of the Orphan Nuclear Receptor ERRγ
por: Lee, Ja Hee, et al.
Publicado: (2012) -
Orphan nuclear receptor ERRγ is a key regulator of human fibrinogen gene expression
por: Zhang, Yaochen, et al.
Publicado: (2017)